P60 Disseminated intravascular coagulation of newborn

Name of the Condition

• Disseminated intravascular coagulation of newborn
• ICD-10-CM Code: P60

Summary

Disseminated intravascular coagulation (DIC) in newborns is a condition characterized by abnormal blood clotting and bleeding due to widespread activation of the coagulation system. It can lead to both thrombotic and hemorrhagic complications, affecting multiple organ systems. This condition requires prompt recognition and management to mitigate risks.

Causes

DIC in newborns may result from various triggers, including sepsis, hypoxia, placental abruption, or severe hemorrhage. Infections, such as bacterial or viral sepsis, are common precipitants. Other causes include trauma, necrotizing enterocolitis, or congenital anomalies affecting coagulation pathways.

Risk Factors

• Sepsis or severe infections in the newborn
• Hypoxic-ischemic injury (e.g., birth asphyxia)
• Placental abruption or other obstetric complications
• Congenital coagulation disorders
• Prematurity or low birth weight
• Maternal conditions (e.g., preeclampsia, chorioamnionitis)

Symptoms

Symptoms vary and may include unexplained bleeding (e.g., petechiae, purpura, or gastrointestinal hemorrhage), bruising, or oozing from puncture sites. Thrombotic signs like organ dysfunction (e.g., renal or hepatic failure) or cyanosis may also occur. Laboratory findings often show abnormal coagulation parameters.

Diagnosis

Diagnosis is based on clinical presentation and laboratory tests, including prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), low fibrinogen, elevated D-dimer, and thrombocytopenia. Imaging or other tests may be used to assess organ involvement or underlying causes.

Treatment Options

Treatment focuses on addressing the underlying trigger (e.g., antibiotics for sepsis) and supporting coagulation. Interventions may include blood product transfusions (e.g., platelets, fresh frozen plasma), anticoagulants (in select cases), and supportive care for organ dysfunction. Close monitoring of coagulation status is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of DIC and the underlying cause. Early intervention improves outcomes, but severe cases may have high morbidity or mortality. Follow-up includes monitoring for complications (e.g., organ damage) and assessing long-term developmental effects.

Complications

Complications can include multi-organ failure, severe bleeding, or thrombotic events (e.g., stroke). Long-term sequelae may involve neurological impairment or chronic organ dysfunction, particularly if DIC is prolonged or severe.

Lifestyle & Prevention

Prevention focuses on managing maternal and neonatal risk factors, such as prompt treatment of infections or obstetric complications. For high-risk newborns, vigilant monitoring and early intervention can reduce the likelihood of developing DIC.

When to Seek Professional Help

Seek immediate medical attention if signs of bleeding, bruising, or organ dysfunction appear in a newborn, especially if risk factors (e.g., sepsis, hypoxia) are present. Early evaluation is critical to initiate timely treatment.

Tips for Medical Coders

Document the underlying cause (e.g., sepsis, hypoxia) and clinical findings supporting DIC. Ensure lab results (e.g., coagulation abnormalities) and treatment details are clearly recorded. Code P60 is specific to newborns; verify no other codes better describe the condition.